Human immunoglobulin (pH4) (Hebei Daan Pharmaceutical)

人免疫球蛋白(pH4)(河北大安制药)

Report date: 2026/05/26 20:00:28

Base Information

Drug NameHuman immunoglobulin (pH4) (Hebei Daan Pharmaceutical)
Drug Alias NamepH4 human immunoglobulin (Hebei Daan Pharmaceutical)静注人免疫球蛋白 (pH4)(河北大安)
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicPurpura, Thrombocytopenic
Global Approved IndicationsPurpura, Thrombocytopenic, Idiopathic
Approved Indications in ChinaPurpura, Thrombocytopenic, Idiopathic
Original Approved Country/TerritoryMainland China
Original Approved Date2020/07/16
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, Idiopathic
Inactive IndicationsPurpura, Thrombocytopenic

Other Information

ATC CodeJ06BA02
Related LinksN/A